NEW YORK, Dec. 4, 2014 /PRNewswire/ -- Levi & Korsinsky
is investigating the Board of Directors of Avanir Pharmaceuticals,
Inc. ("Avanir" or "the Company") (NasdaqGS: AVNR) for possible
breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to Otsuka Pharmaceutical
Co., Ltd.
Click here to learn more about the investigation:
http://zlk.9nl.com/avanirpharmaceuticals-avnr.
Under the terms of the transaction, Avanir shareholders will
receive a $17.00 for each share of
Avanir stock they own. The investigation concerns whether the Board
of Avanir breached their fiduciary duties to stockholders by
failing to adequately shop the Company before agreeing to enter
into this transaction, and whether Otsuka Pharmaceutical Co., Ltd.
is underpaying for Avanir shares. In particular, at least one
analyst set a price target of $21.00
per Avanir share.
If you own Avanir common stock and wish to obtain additional
information, please contact Joseph E. Levi,
Esq. either via email at jlevi@zlk.com or by telephone at
(212) 363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/avanirpharmaceuticals-avnr.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/avnr-investor-alert-levi--korsinsky-llp-announces-investigation-of-the-board-of-directors-of-avanir-pharmaceuticals-inc-in-connection-with-the-fairness-of-the-sale-of-the-company-to-otsuka-pharmaceutical-co-ltd----avnr-300005023.html
SOURCE Levi & Korsinsky, LLP